Preclinical Study

Preclinical study on Uthever™ is being conducted by Effepharm, which would basically include:

(1) Acute toxicity study
(2) 90-day subchronic oral study
(3) Bacterial mutagenesis-Ames
(4) In vitro cytogenetics-Chromosome aberration test in CHO cell lines
(5) In vivo mammalian test-Chromosome aberration test in Mouse

More animal studies on efficacy are also being conducted, please keep tuned.